[
    [
        {
            "time": "",
            "original_text": "药明康德: WuXi AppTec (BVI)已合计减持857.09万股 减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "WuXi AppTec",
                    "减持",
                    "857.09万股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德: WuXi AppTec (BVI)已合计减持857.09万股 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "减持！药明康德：股东减持公司股份约857万股 减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "股东",
                    "减持",
                    "857万股"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "减持！药明康德：股东减持公司股份约857万股 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "药明康德：WuXi AppTec (BVI) Inc.集中竞价减持857.09万股减持数过半 减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "WuXi AppTec",
                    "集中竞价",
                    "减持",
                    "857.09万股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德：WuXi AppTec (BVI) Inc.集中竞价减持857.09万股减持数过半 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "药明康德：WuXi AppTec (BVI) Inc.减持0.52%公司股份 减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "WuXi AppTec",
                    "减持",
                    "0.52%"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德：WuXi AppTec (BVI) Inc.减持0.52%公司股份 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "北上持续加仓：茅台仍是最爱，牛奶猪肉遭抛售",
            "features": {
                "keywords": [
                    "北上资金",
                    "加仓",
                    "茅台",
                    "牛奶",
                    "猪肉",
                    "抛售"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "食品饮料",
                    "农业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北上持续加仓：茅台仍是最爱，牛奶猪肉遭抛售",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "药明康德：收入端略超市场预期，核心业务中国区实验室业务保持强劲增长",
            "features": {
                "keywords": [
                    "药明康德",
                    "收入端",
                    "市场预期",
                    "实验室业务",
                    "强劲增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德：收入端略超市场预期，核心业务中国区实验室业务保持强劲增长",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【华西医药崔文亮团队】《医药生物行业点评报告：两会医药议题解读：疫苗、创新药、IVD和医疗设备等领域继续成为关注焦点》",
            "features": {
                "keywords": [
                    "华西医药",
                    "两会",
                    "医药议题",
                    "疫苗",
                    "创新药",
                    "IVD",
                    "医疗设备"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【华西医药崔文亮团队】《医药生物行业点评报告：两会医药议题解读：疫苗、创新药、IVD和医疗设备等领域继续成为关注焦点》",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "资金汇集白马股，A股千亿市值军团扩至近百家",
            "features": {
                "keywords": [
                    "资金汇集",
                    "白马股",
                    "A股",
                    "千亿市值",
                    "军团"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "资金汇集白马股，A股千亿市值军团扩至近百家",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]